Visage to deploy cloud imaging platform across UMMS
The 5-year contract covers cloud deployment of Visage 7 Viewer and Visage 7 Workflow across the University of Maryland Medical System.
Pro Medicus subsidiary Visage Imaging has signed a 5-year, $14.4M contract with the University of Maryland Medical System to deploy the Visage 7 enterprise imaging platform.
The agreement covers Visage 7 Viewer and Visage 7 Workflow. The platform will be deployed in the cloud across UMMS’s network of academic, community, and specialty hospitals.
Rollout planning is set to begin immediately, with go-live targeted for early 2027. The deal uses a transaction-based licensing model, according to Pro Medicus.
UMMS includes the University of Maryland Medical Center, the Marlene and Stewart Greenebaum Comprehensive Cancer Center, the University of Maryland Children’s Hospital, and the R Adams Cowley Shock Trauma Center.
Pro Medicus described the deal as a 5-year A$23M contract in its Australian filing. The U.S. dollar value was reported as $14.4M.
Visage Imaging is a wholly owned subsidiary of Pro Medicus, with headquarters in San Diego and Berlin. Pro Medicus is headquartered in Melbourne, Australia.
Sources
- PME signs 5-year, A$23M contract with University of Maryland Medical System. Investor relations
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.
I-MED sale gives Jardines 215-clinic radiology network
Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.
Expected Russell addition puts Hyperfine in small-cap benchmarks
FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.
Curium approach puts Lantheus deal value near $7B
Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST Pro brings contrast tracking upgrade to U.S. cath labs
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.